Skip to main content
. 2020 Jul 2;10:10835. doi: 10.1038/s41598-020-67783-z

Figure 5.

Figure 5

Antiviral activity of VDR agonists against DENV infection on HepG2 cells. HepG2 cells were mock-infected or infected with DENV 2 at MOI 5 for 2 h, followed by the treatment with 10 μM of ZD-1, ZD-2, ZD-3, ZD-5 and ZD-6 for 24 h.p.i. The treated cells were collected and level of infection determined by flow cytometry. p value; *< 0.05, **< 0.01, ***< 0.001 for significance. The experiment was performed independently in triplicate.